MagNap Clinical Trial Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$2.9M
- Investors
-
1
MagNap Clinical Trial General Information
Description
Developer of a surgical device designed for the treatment of obstructive sleep apnea. The company's device specializes in offering a new minimally invasive surgical treatment for certain types of sleep apnea, enabling healthcare professionals to avail efficient and advanced surgical tools and equipment to serve their patients.
Contact Information
Website
www.magnapsleepapnea.netCorporate Office
- 1600 Divisadero Street
- 5th floor
- San Francisco, CA 94115
- United States
Corporate Office
- 1600 Divisadero Street
- 5th floor
- San Francisco, CA 94115
- United States
MagNap Clinical Trial Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 19-Jun-2017 | $2.9M | Completed | Pre-Clinical Trials |
MagNap Clinical Trial Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
MagNap Clinical Trial Patents
MagNap Clinical Trial Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240252042-A1 | Tissue evaluation for apnea therapy | Pending | 27-Jan-2023 |
MagNap Clinical Trial Executive Team (2)
| Name | Title | Board Seat |
|---|---|---|
| Michael Harrison MD | Founder & Chief Executive Officer |
MagNap Clinical Trial Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Douglas Crawford Ph.D | Mission Bay Capital | Board Member |
MagNap Clinical Trial Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mission Bay Capital | Venture Capital | Minority |
MagNap Clinical Trial FAQs
-
When was MagNap Clinical Trial founded?
MagNap Clinical Trial was founded in 2013.
-
Who is the founder of MagNap Clinical Trial?
Michael Harrison MD is the founder of MagNap Clinical Trial.
-
Who is the CEO of MagNap Clinical Trial?
Michael Harrison MD is the CEO of MagNap Clinical Trial.
-
Where is MagNap Clinical Trial headquartered?
MagNap Clinical Trial is headquartered in San Francisco, CA.
-
What industry is MagNap Clinical Trial in?
MagNap Clinical Trial’s primary industry is Therapeutic Devices.
-
Is MagNap Clinical Trial a private or public company?
MagNap Clinical Trial is a Private company.
-
What is the current valuation of MagNap Clinical Trial?
The current valuation of MagNap Clinical Trial is .
-
What is MagNap Clinical Trial’s current revenue?
The current revenue for MagNap Clinical Trial is .
-
How much funding has MagNap Clinical Trial raised over time?
MagNap Clinical Trial has raised $2.9M.
-
Who are MagNap Clinical Trial’s investors?
Mission Bay Capital has invested in MagNap Clinical Trial.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
